TY - JOUR
T1 - Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar typhimurium infection
AU - Medina, Freddy A.
AU - De Almeida, Cecilia J.
AU - Dew, Elliott
AU - Li, Jiangwei
AU - Bonuccelli, Gloria
AU - Williams, Terence M.
AU - Cohen, Alex W.
AU - Pestell, Richard G.
AU - Frank, Philippe G.
AU - Tanowitz, Herbert B.
AU - Lisanti, Michael P.
PY - 2006/12
Y1 - 2006/12
N2 - A number of studies have shown an association of pathogens with caveolae. To this date, however, there are no studies showing a role for caveolin-1 in modulating immune responses against pathogens. Interestingly, expression of caveolin-1 has been shown to occur in a regulated manner in immune cells in response to lipopolysaccharide (LPS). Here, we sought to determine the role of caveolin-1 (Cav-1) expression in Salmonella pathogenesis. Cav-1-/- mice displayed a significant decrease in survival when challenged with Salmonella enterica serovar Typhimurium. Spleen and tissue burdens were significantly higher in Cav-1-/- mice. However, infection of Cav-1-/- macrophages with serovar Typhimurium did not esult in differences in bacterial invasion. In addition, Cav-1-/- mice displayed increased production of inflammatory cytokines, chemokines, and nitric oxide. Regardless of this, Cav-1-/- mice were unable to control the systemic infection of Salmonella. The increased chemokine production in Cav-1-/- mice resulted in greater infiltration of neutrophils into granulomas but did not alter the number of granulomas present. This was accompanied by increased necrosis in the liver. However, Cav-1-/- macrophages displayed increased inflammatory responses and increased nitric oxide production in vitro in response to Salmonella LPS. These results show that caveolin-1 plays a key role in regulating anti-inflammatory responses in macrophages. Taken together, these data suggest that the increased production of toxic mediators from macrophages lacking caveolin-1 is likely to be responsible for the marked susceptibility of caveolin-1-deficient mice to S. enterica serovar Typhimurium.
AB - A number of studies have shown an association of pathogens with caveolae. To this date, however, there are no studies showing a role for caveolin-1 in modulating immune responses against pathogens. Interestingly, expression of caveolin-1 has been shown to occur in a regulated manner in immune cells in response to lipopolysaccharide (LPS). Here, we sought to determine the role of caveolin-1 (Cav-1) expression in Salmonella pathogenesis. Cav-1-/- mice displayed a significant decrease in survival when challenged with Salmonella enterica serovar Typhimurium. Spleen and tissue burdens were significantly higher in Cav-1-/- mice. However, infection of Cav-1-/- macrophages with serovar Typhimurium did not esult in differences in bacterial invasion. In addition, Cav-1-/- mice displayed increased production of inflammatory cytokines, chemokines, and nitric oxide. Regardless of this, Cav-1-/- mice were unable to control the systemic infection of Salmonella. The increased chemokine production in Cav-1-/- mice resulted in greater infiltration of neutrophils into granulomas but did not alter the number of granulomas present. This was accompanied by increased necrosis in the liver. However, Cav-1-/- macrophages displayed increased inflammatory responses and increased nitric oxide production in vitro in response to Salmonella LPS. These results show that caveolin-1 plays a key role in regulating anti-inflammatory responses in macrophages. Taken together, these data suggest that the increased production of toxic mediators from macrophages lacking caveolin-1 is likely to be responsible for the marked susceptibility of caveolin-1-deficient mice to S. enterica serovar Typhimurium.
UR - http://www.scopus.com/inward/record.url?scp=33845507080&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845507080&partnerID=8YFLogxK
U2 - 10.1128/IAI.00949-06
DO - 10.1128/IAI.00949-06
M3 - Article
C2 - 16982844
AN - SCOPUS:33845507080
SN - 0019-9567
VL - 74
SP - 6665
EP - 6674
JO - Infection and Immunity
JF - Infection and Immunity
IS - 12
ER -